ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Peter, J.
Right arrow Articles by Podszus, T
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Peter, J.
Right arrow Articles by Podszus, T
Eur Respir J 1995; 8: 1572-1583
Copyright © ERS Journals Ltd 1995

Original Articles

Manifestations and consequences of obstructive sleep apnoea

JH Peter, U Koehler, L Grote, and T Podszus

Over the last two decades the diagnostic tools used in sleep medicine have developed enormously, making it possible to study the interaction of sleep-related breathing disorders (SRBD) with cardiovascular function and the autonomic nervous system, as well as the effects of SRBD on a variety of physiological processes during wakefulness. Different modes of nasal ventilation are now available, allowing all forms of SRBD to be treated. If early diagnosis and treatment are provided, the acute and long-term sequelae of SRBD can be prevented. In addition to the care and treatment of patients with severe obstructive sleep apnoea syndrome (OSAS), future patient management will need to focus on patients with milder forms of obstructive sleep apnoea (OSA). In particular, the consequences of SRBD on cardiac arrhythmias, arterial hypertension and hypersomnolence are discussed, considering epidemiological, clinical, diagnostic and therapeutic aspects. Some economical issues arising from SRBD are also discussed, and the authors conclude that a Europewide programme for early detection, treatment and prevention of SRBD is required. This could make a large contribution to the reduction of cardiovascular morbidity and mortality and also reduce the incidence of "human error catastrophes" due to hypersomnolence.


This article has been cited by other articles:


Home page
 Exp PhysiolHome page
M. Dunleavy, M. Dooley, D. Cox, and A. Bradford
Chronic intermittent asphyxia increases platelet reactivity in rats
Exp Physiol, May 1, 2005; 90(3): 411 - 416.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
K. D. O'Halloran, M. McGuire, T. O'Hare, and A. Bradford
Chronic Intermittent Asphyxia Impairs Rat Upper Airway Muscle Responses to Acute Hypoxia and Asphyxia*
Chest, July 1, 2002; 122(1): 269 - 275.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
C. Zoccali, F. Mallamaci, and G. Tripepi
Sleep Apnea in Renal Patients
J. Am. Soc. Nephrol., December 1, 2001; 12(12): 2854 - 2859.
[Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
C. Zoccali
Sleep apnoea and nocturnal hypoxaemia in dialysis patients: mere risk-indicators or causal factors for cardiovascular disease?
Nephrol. Dial. Transplant., December 1, 2000; 15(12): 1919 - 1921.
[Full Text] [PDF]

Home page
 Eur Heart JHome page
K.G. van Houwelingen, R. van Uffelen, and A.C.M. van Vliet
The sleep apnoea syndromes
Eur. Heart J., June 2, 1999; 20(12): 858 - 866.
[PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by the European Respiratory Society.